P Huovinen

Author PubWeight™ 122.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997 9.63
2 Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993 4.83
3 Antimicrobial resistance. Is a major threat to public health. BMJ 1998 4.18
4 A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 1998 3.97
5 Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother 1999 2.73
6 Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother 1998 2.33
7 Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 1999 2.33
8 katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother 1996 1.82
9 Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis 2001 1.78
10 Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis 1994 1.75
11 Outbreak of diarrhoea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet 1990 1.65
12 Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol 1994 1.63
13 A novel dihydrofolate reductase cassette inserted in an integron borne on a Tn21-like element. Antimicrob Agents Chemother 1993 1.51
14 Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis 1997 1.50
15 Control of antimicrobial resistance: time for action. The essentials of control are already well known. BMJ 1998 1.48
16 Antibiotic resistance. How wild are wild mammals? Nature 2001 1.48
17 Guideline for the management of acute sore throat. Clin Microbiol Infect 2012 1.48
18 Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995 1.43
19 In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria. Antimicrob Agents Chemother 1987 1.41
20 Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis 1998 1.36
21 Evaluation of five different methods to prepare bacterial extracts for the identification of beta-lactamases by isoelectric focusing. J Antimicrob Chemother 1993 1.34
22 A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother 2000 1.33
23 Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis 1990 1.29
24 Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. J Clin Microbiol 1991 1.27
25 In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother 2001 1.27
26 Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997. J Antimicrob Chemother 1999 1.24
27 Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis 1995 1.22
28 Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. Vet Rec 2004 1.21
29 Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia 2011 1.20
30 Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis 1990 1.20
31 Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy. Antimicrob Agents Chemother 1992 1.20
32 Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis 2001 1.19
33 Erythromycin resistance genes in group A streptococci of different geographical origins. The Macrolide Resistance Study Group. J Antimicrob Chemother 2000 1.19
34 Antimicrobial susceptibility of Enterobacteriaceae isolated from vegetables. J Antimicrob Chemother 1999 1.17
35 Trimethoprim resistance in Finland after five years' use of plain trimethoprim. Br Med J 1980 1.16
36 Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis 1992 1.14
37 Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother 1984 1.10
38 Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis 1998 1.07
39 Analysis of genetic localization of the type I trimethoprim resistance gene from Escherichia coli isolated in Finland. Antimicrob Agents Chemother 1991 1.06
40 In vitro susceptibility of Streptococcus mutans to chlorhexidine and six other antimicrobial agents. Antimicrob Agents Chemother 1993 1.06
41 Aminoglycoside resistance among blood culture isolates. J Clin Microbiol 1984 1.05
42 Bacteriotherapy: the time has come. BMJ 2001 1.03
43 The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland. J Antimicrob Chemother 1990 1.01
44 Dental amalgam fillings and the amount of organic mercury in human saliva. Caries Res 2001 0.99
45 Erythromycin resistance in group A streptococci. Lancet 1989 0.99
46 Antibiotic use by indication: a basis for active antibiotic policy in the community. Scand J Infect Dis 2001 0.97
47 Streptococcus pneumoniae isolates resistant to telithromycin. Antimicrob Agents Chemother 2006 0.95
48 Indication-based use of antimicrobials in Finnish primary health care. Description of a method for data collection and results of its application. Scand J Prim Health Care 1999 0.95
49 Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. Clin Infect Dis 1995 0.95
50 Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 2012 0.93
51 Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002. Antimicrob Agents Chemother 2005 0.93
52 Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin. Eur J Clin Microbiol Infect Dis 2002 0.93
53 Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland. J Antimicrob Chemother 1997 0.92
54 Cohort study of bacterial species causing urinary tract infection and urinary tract abnormalities in children. BMJ 1999 0.91
55 Reports on surveillance of antimicrobial resistance in individual countries. Clin Infect Dis 1997 0.90
56 Emergence of trimethoprim resistance in relation to drug consumption in a Finnish hospital from 1971 through 1984. Antimicrob Agents Chemother 1986 0.89
57 Nosocomial Staphylococcus epidermidis septicaemia among very low birth weight neonates in an intensive care unit. J Hosp Infect 1991 0.89
58 Trimethoprim resistance in Escherichia coli isolates from a geriatric unit. Antimicrob Agents Chemother 1990 0.89
59 Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings. Antimicrob Agents Chemother 1995 0.88
60 Trimethoprim resistance in hospitals. Br Med J (Clin Res Ed) 1982 0.88
61 Customer-oriented counseling for physical activity in older people: study protocol and selected baseline results of a randomized-controlled trial (ISRCTN 07330512). Scand J Med Sci Sports 2007 0.88
62 Emergence of trimethoprim resistance in fecal flora. Antimicrob Agents Chemother 1985 0.87
63 Erythromycin resistance of group A streptococci from throat samples is related to age. Pediatr Infect Dis J 1997 0.87
64 Prescribing antimicrobial agents for dogs and cats via university pharmacies in Finland--patterns and quality of information. Acta Vet Scand 2005 0.86
65 Screening for antimicrobial resistance in fecal samples by the replica plating method. J Clin Microbiol 1995 0.86
66 Problem of antimicrobial resistance of fecal aerobic gram-negative bacilli in the elderly. Antimicrob Agents Chemother 1996 0.85
67 Multiresistance in Staphylococcus spp. blood isolates in Finland with special reference to the distribution of the mecA gene among the Staphylococcus epidermidis isolates. The Finnish Study Group for Antimicrobial Resistance. APMIS 1995 0.84
68 Trimethoprim-resistant Escherichia coli in a geriatric hospital. J Infect 1984 0.84
69 Evaluation of plasmid-encoded beta-lactamase resistance in Escherichia coli blood culture isolates. Eur J Clin Microbiol Infect Dis 1988 0.84
70 Antimicrobial resistance in Neisseria gonorrhoeae in Finland, 1976 to 1995. The Finnish Study Group For Antimicrobial Resistance. Sex Transm Dis 1997 0.84
71 Transferable trimethoprim resistance in three Finnish hospitals. J Antimicrob Chemother 1983 0.84
72 Clinical scoring system in the evaluation of adult pharyngitis. Arch Otolaryngol Head Neck Surg 1993 0.82
73 Effect of ampicillin versus cefuroxime on the emergence of beta-lactam resistance in faecal Enterobacter cloacae isolates from neonates. J Antimicrob Chemother 1993 0.82
74 Susceptibility of Streptococcus mutans and Streptococcus sobrinus to antimicrobial agents after short-term oral chlorhexidine treatments. Eur J Oral Sci 1995 0.82
75 Reliability of biotinylated DNA probes in colony hybridization: evaluation of an improved colony lysis method for detection of TEM-1 beta-lactamase. Mol Cell Probes 1988 0.82
76 Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli. J Infect 1994 0.82
77 Antimicrobial resistance levels of enterobacteria isolated from minced meat. J Antimicrob Chemother 1999 0.80
78 Trimethoprim resistance of Escherichia coli in outpatients in Finland after ten years' use of plain trimethoprim. J Antimicrob Chemother 1985 0.80
79 Epidemiology of the colonization of inpatients and outpatients with ciprofloxacin-resistant coagulase-negative staphylococci. Clin Infect Dis 1995 0.79
80 Colonization of resistant faecal aerobic gram-negative bacilli among geriatric patients in hospital and the community. J Antimicrob Chemother 1996 0.79
81 Increase of antimicrobial resistance of faecal aerobic gram-negative bacteria in a geriatric hospital. Age Ageing 1996 0.79
82 Immunochemical analysis of the extracellular slime substance of Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis 1990 0.79
83 Antimicrobial resistance of fecal aerobic gram-negative bacilli in different age groups in a community. Antimicrob Agents Chemother 1996 0.79
84 Antibiotic susceptibility of coagulase-negative staphylococcal blood isolates with special reference to adherent, slime-producing Staphylococcus epidermidis strains. Scand J Infect Dis 1991 0.79
85 Rapid high-pressure liquid chromatographic method for analysis of phenoxymethylpenicillin in human serum. Antimicrob Agents Chemother 1984 0.79
86 [Recommended treatment of acute otitis]. Duodecim 1999 0.79
87 Recording of antimicrobial resistance of urinary tract isolates--effect of repeat samples on resistance levels. J Antimicrob Chemother 1985 0.78
88 FiRe works - the Finnish Study Group for Antimicrobial Resistance (FiRe). Euro Surveill 2000 0.78
89 Screening for antimicrobial resistance in normal bacterial flora of the skin using the replica plating method. Eur J Clin Microbiol Infect Dis 2000 0.78
90 Infrequent isolation of multiresistant Acinetobacter baumannii from the staff tending a colonized patient with severe burns. Infect Control Hosp Epidemiol 2001 0.78
91 Reliability of disc diffusion susceptibility testing of Streptococcus pneumoniae and adjustment of laboratory-specific breakpoints. Finnish Study Group for Antimicrobial Resistance. J Antimicrob Chemother 1998 0.78
92 Disk diffusion susceptibility tests: need for laboratory-specific breakpoints. Scand J Infect Dis 1995 0.78
93 Reliability of a disk diffusion method using semiconfluent growth in the determination of aminoglycoside resistance. Acta Pathol Microbiol Immunol Scand B 1986 0.77
94 Prescription of antimicrobial agents to elderly people in relation to the type of infection. Age Ageing 1997 0.77
95 Antimicrobial resistance in Haemophilus influenzae isolated from blood, cerebrospinal fluid, middle ear fluid and throat samples of children. A nationwide study in Finland in 1988-1990. Scand J Infect Dis 1995 0.77
96 Plasmid-mediated beta-lactamases among aminoglycoside resistant gram-negative bacilli. Scand J Infect Dis 1989 0.76
97 Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob Agents Chemother 2000 0.76
98 False-positive Clostridium difficile latex agglutination tests. Lancet 1990 0.76
99 Comparison of ciprofloxacin or trimethoprim therapy for venous leg ulcers: results of a pilot study. J Am Acad Dermatol 1994 0.76
100 Yersinia enterocolitica plasmid in fecal flora of patients with reactive arthritis. J Infect Dis 1986 0.75
101 Analysis of the relationship between bacterial adherence and extracellular production of mannose, galactose, glucose and ribose in Staphylococcus epidermidis and Staphylococcus hominis. Eur J Clin Microbiol Infect Dis 1990 0.75
102 [The use of impact factors in assessing the quality of international journals]. Duodecim 1992 0.75
103 Fine-needle aspiration biopsy, curettage, and swab samples in bacteriologic analysis of leg ulcers. Arch Dermatol 1992 0.75
104 Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents. Scand J Infect Dis 1993 0.75
105 [Acute otitis media in a child]. Duodecim 1998 0.75
106 [Pharyngitis]. Duodecim 1992 0.75
107 Association af changes in the bacterial ecology of bovine mastitis with changes in the use of milking machines and antibacterial drugs. Acta Vet Scand 1994 0.75
108 Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Finnish Study Group for Antimicrobial Resistance. Eur J Clin Microbiol Infect Dis 1994 0.75
109 Evaluation of the TPX MRSA assay for the detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2011 0.75
110 Trimethoprim highly resistant, sulphonamide sensitive bacteria. Lancet 1981 0.75
111 Detecting erythromycin resistance in Streptococcus pyogenes: reliability of the disk diffusion method and the breakpoint susceptibility testing method. Finnish Study Group for Antimicrobial Resistance (FIRE). Scand J Infect Dis 1995 0.75
112 [Staphylococcus saprophyticus as a urinary tract pathogen]. Duodecim 1985 0.75
113 The effect of a combination of Iso-Sensitest agar and ampicillin on the detection of enterobacter beta-lactamase. J Antimicrob Chemother 1998 0.75
114 Human onychomycosis caused by Trichophyton equinum transmitted from a racehorse. Br J Dermatol 1998 0.75
115 [Fluoroquinolones]. Duodecim 1988 0.75
116 Clinical microbiology laboratories do not always detect resistance of Haemophilus influenzae with disk or tablet diffusion methods. Finnish Study Group for Antimicrobial Resistance (FiRe). APMIS 1998 0.75
117 Trimethoprim resistance. Lancet 1986 0.75
118 Semihard scattering unraveled from collective dynamics by two-pion azimuthal correlations in 158A GeV/c Pb+Au collisions. Phys Rev Lett 2004 0.75
119 Influence of shear viscosity of quark-gluon plasma on elliptic flow in ultrarelativistic heavy-ion collisions. Phys Rev Lett 2011 0.75
120 Use of gas-liquid chromatography for subgrouping coagulase-negative staphylococci during a nosocomial sepsis outbreak. Eur J Clin Microbiol Infect Dis 1995 0.75
121 Problems in interpretation of piperacillin susceptibility of TEM-1 producing Escherichia coli in the disk diffusion test. Eur J Clin Microbiol Infect Dis 1991 0.75
122 Carumonam in the treatment of severe and complicated urinary tract infections. Chemioterapia 1987 0.75
123 Infection control measures to limit the spread of Clostridium difficile. Introduction. Clin Microbiol Infect 2008 0.75
124 Analysis of beta-lactamase production in ampicillin-resistant Escherichia coli isolated from blood cultures 1983-1989. Eur J Clin Microbiol Infect Dis 1991 0.75
125 Aspoxicillin versus piperacillin in severe abdominal infections--a comparative phase III study. J Antimicrob Chemother 1994 0.75
126 Testing of methicillin resistance by in vitro susceptibility and the presence of the mecA gene in clinical Staphylococcus aureus isolates in Finland. Scand J Infect Dis 1995 0.75